PHAT
Phathom Pharmaceuticals, Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 3:41:43 PM EST
5.09USD-4.057%(-0.21)683,259
PHAT Financials
In Q3 FY 2026 (ended ), Phathom Pharmaceuticals, Inc. Common Stock (PHAT) reported revenue of $84.72M, net income of −$13.9M, operating cash flow of $1.84M, and assets of $345.02M (filed ).
Loading financial statements…